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A novel gene transfer system utilizing polycation liposomes (PCLs), obtained by modifying liposomes with cetyl polyethylenimine (PEI),
was previously developed (Gene Ther. 7 (2002) 1148). PCLs show notable transfection efficiency with low cytotoxicity. However, the
mechanism of PCL-mediated gene transfer is still unclear. In this study, we examined the intracellular trafficking of PCL–DNA complexes
by using HT1080 cells, fluorescent probe-labeled materials, and confocal laser scan microscopy. We found that the PCL–DNA complexes
were taken up into cells by the endosomal pathway, since both cellular uptake of the complex and gene expression were blocked by
wortmannin, an inhibitor of this pathway. We also observed that the plasmid DNA and cetyl PEI complex became detached from the PCL
lipids and was preferentially transferred into the nucleus in the form of the complex, whereas the PCL lipids remained in the cytoplasmic
area, possibly in the endosomes. In fact, nigericin, which dissipates the pH gradient across the endosomal membrane, inhibited the
detachment of lipids from the PCL–DNA complex and subsequent gene expression. Taken together, our data indicate the following
mechanism for gene transfer by PCLs: PCLs effectively transfer DNA to endosomes and release cetyl PEI–DNA complexes into the cytosol.
Furthermore, cetyl PEI also contributes to gene entry into the nucleus.
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Present gene transfer systems are basically classified two
categories, namely, viral systems and non-viral systems.
Among non-viral gene transfer systems, cationic liposomes
[1–3] and polycations [4,5] are widely investigated. Cat-
ionic liposomes form a complex with anionic DNA mole-
cules and are thought to deliver DNA through the
endosomal pathway [6]. The precise mechanism for gene
transfection mediated by cationic liposomes is still unclear;
however, fusion with endosomal membrane or destabiliza-
tion of the membrane by cationic liposomes may trigger the
effective cytosolic delivery of DNA, because the incorpo-0005-2736/$ - see front matter D 2003 Elsevier B.V. All rights reserved.
doi:10.1016/j.bbamem.2003.10.012
Abbreviations: DOPE, dioleoylphosphatidylethanolamine; DPPC, di-
palmitoylphosphatidylcholine; FBS, fetal bovine serum; GFP, green
fluorescent protein; PBS, phosphate-buffered saline; PCL, polycation
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lipid that forms a hexagonal II phase at low pH, as a
component of cationic liposomes is known to enhance the
transfection efficiency [7,8]. On the other hand, polycations
such as polyethylenimine (PEI) with the molecular weight
of 25,000 to 50,000 also form a complex with anionic DNA
molecules and are taken up into the target cells via the
endosomal pathway. In the case of polycations, however,
unlike that of cationic liposomes, the DNA released into the
cytoplasm from endosomes, due to the proton-sponge effect
of PEI, may further be delivered to the nucleus by the
polycation [9,10].
We previously developed the polycation liposome (PCL)
as a novel non-viral gene transfer system that possesses the
advantages of both cationic liposomes and polycations for
gene delivery [11,12]. PCLs are simply prepared by mod-
ification of the liposomal surface with cetylated PEI (an
average molecular weight of PEI is 600 to 1800). PCL
showed various advantageous properties such as high effi-
ciency of gene transfer (Fig. 1 from Ref. [11] with a
modification), low cytotoxicity, applicability for in vivo
Fig. 1. Gene transfer activity of PCL and other cationic liposomes. PCL,
DOTAP liposome, DMRIE liposome, or LipofectAMINE was complexed
with 1 Ag of pEGFP-C1 plasmid DNA at various cationic lipid-to-DNA unit
ratios. COS-1 cells (1105 cells/dish) were incubated with the liposome/
plasmid DNA complexes for 3 h at 37 jC. At 48 h after transfection, the
cells were solubilized; and fluorescence intensity was then determined (Ex.
493 nm, Em. 510 nm). Data represent the meanF S.D. of optimum
conditions for each liposome (n= 3). Data are modified from Ref. [11].
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of serum. The mechanism of PCL-mediated gene transfer,
however, is not clear at present. In the present study, for
elucidating the mechanism, we investigated by confocal
laser scan microscopy the intracellular trafficking of PCL/
DNA complexes by using HT1080 cells and plasmid DNA,
liposomal lipid, and cetyl PEI labeled with various fluores-
cent probes. The results indicate that the PCL contributes
not only to effective delivery of DNA to the cytosol via the
endosomal pathway but also to effective entry of DNA into
nucleus. Therefore, PCL might show efficiency of gene
transfer superior to that of other systems.2. Materials and methods
2.1. Preparation of PCL
Synthesis of cetyl PEI was performed as described
previously [20]. In brief, PEI with an average molecular
weight of 1800 (Dow Chemical) was purified by ultrafiltra-
tion. PEI (1 g) was refluxed with 1.39-g cetyl bromide in the
presence of triethylamine in chloroform solution. After
purification of the cetyl PEI, the products were identified
by NMR. Integration of the proton NMR spectrum of the
product in D2O indicated that 18.9 mol% of cetyl groups per
residue mole of ethylenimine unit had been grafted into the
polymer. The stoichiometric formula of the polymer was
(C2H4N)43(C16H33)8.
FITC-labeling of cetyl PEI was performed as follows:
FITC (49.9 mg, 126 Amol) was dissolved in 8.0 ml of
ethanol, and the solution was slowly dropped into a solution
of cetyl PEI (510.0 mg, 126 Amol) that had been dissolved
in 4.0-ml ethanol and was then stirred at room temperature
for 24 h. After evaporation, the resulting solid was dissolved
in 20% ethanol aqueous solution, and ultrafiltered with
excess 20% ethanol aqueous solution for 2 days. Finally,
the solution was lyophilized. The conjugation of FITC wasconfirmed by conducting a TLC assay using methanol/
chloroform (1:1,v/v) as the developing solvent. All process-
es were done in the dark with minimal room light.
PCLs were prepared as follows: Cetyl PEI and dioleoyl-
phosphatidylethanolamine (DOPE, Nippon Fine Chemical
Co. Ltd., Hyogo, Japan) (0.05:1 as molar ratio) with or
without 5 mol% of NBD-PE (Avanti Polar Lipids Inc.) were
dissolved in chloroform, dried under reduced pressure, and
stored in vacuo for at least 1 h. The liposomes were
produced by hydration of the thin lipid film with sterilized
distilled water (1 mM as final concentration of DOPE). This
liposomal solution was freeze-thawed three times by using
liquid nitrogen, and sonicated for 10 min with a bath-type
sonicator. FITC-cetyl PEI/PCL was prepared similarly ex-
cept that FITC-cetyl PEI was used instead of non-labeled
cetyl PEI.
2.2. Preparation PCL–DNA complex
A plasmid encoding the green fluorescent protein (GFP)
gene, gWIZk-GFP (Gene Therapy Systems, Inc.), was
amplified in E. coli JM109 and purified by QIAfilterk
Plasmid Mega Kit (Qiagen). The plasmid gave a single band
by agarose gel electrophoresis. Plasmids were dissolved in
Tris–EDTA buffer, pH 8.0. Plasmid DNA was labeled with
rhodamine by using pGeneGripk Rhodamine PNA Label
(Gene Therapy Systems). PCL–plasmid DNA complexes
were prepared as follows: 1 Ag of plasmid DNA was mixed
with PCL solution (1 mM as DOPE) at the optimal PEI
nitrogen to DNA phosphorus (N/P) ratio of 24. After the
addition of RPMI1640, the mixture was incubated for 20
min at room temperature.
2.3. Transfection and confocal laser scan microscopy
Human fibrosarcoma HT-1080 (1105 cells/35-mm dish
pre-loaded with a 22 22 mm sterile glass coverslip) were
cultured overnight in 2 ml of RPMI1640 medium supple-
mented with 10% fetal bovine serum (FBS, Sigma; 10%
FBS-RPMI) under a humidified atmosphere of 5% CO2 in
air. After the cells had been washed twice with RPMI1640,
PCL–DNA complexes (0.25 ml, 1 Ag DNA) were added,
and the cells were incubated at 37 jC for appropriate
periods of time, after which they were fixed for observation
under a confocal laser scan microscope. If the incubation
time was more than 2 h, the incubation medium was
replaced once with 2 ml of 10% FBS-RPMI, at 2 h after
the addition of the PCL–DNA complexes. For the assay in
the presence of inhibitors, cells were preincubated for 30
min in the presence of 10 AM wortmannin, 10 AM nigericin
or 1%DMSO as the control before the addition of PCL–
DNA complexes, and the inhibitors remained until the cells
were fixed.
At the appropriate time points, the PCL–DNA com-
plexes or 10% FBS-RPMI1640 was removed, and the cells
were washed twice with phosphate-buffered saline (PBS)
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hyde in PBS for 20 min at room temperature. After the cells
had been washed with PBS, they were sequentially incu-
bated with 3% bovine serum albumin (BSA) and 0.1%
saponin in PBS for 20 min and 10 mg/ml 4V, 6-diamidino-2-
phenylindole (DAPI) for 15 min. After a wash with 0.1%
saponin in PBS, the coverslips were mounted on glass
microscope slides by using Prolongk Antifade Kit (Mo-
lecular Probes). The fluorescence was examined with a
LSM510 confocal laser scan microscope (Carl Zeiss, Co.,
Ltd.). An argon laser (488-nm excitation) was used to
induce the green fluorescence of NBD-PE and FITC; a
helium-neon laser (543 nm), to excite the red fluorescence
of rhodamine; and a UV laser (364 nm) to obtain the blue
fluorescence of DAPI. The focal plane of each sample was
set on the middle of nuclei of the most of cells. Nomarski
differential interference contrast images were also obtained.
2.4. Luciferase assay
A plasmid encoding the luciferase gene, pCAG-Luc3,
which was kindly provided by DNAVEC Research Inc., was
used as a reporter gene. HT-1080 cells (105 cells per 35-mm
dish) cultured overnight in 10% FBS-RPMI1640 were
washed twice with RPMI1640, and wortmannin or nigericin
in RPMI1640 was added to them. Cells were preincubatedFig. 2. Intracellular trafficking of PCL lipid and plasmid DNA in HT-1080 cells
labeled PCL(cetyl PEI/DOPE/NBD-PE= 0.05:1:0.05) and rhodamine-labeled pla
examined by confocal laser scan microscopy. The focal plane of each sample was
shown in green; and the rhodamine-labeled plasmid DNA, in red. The cells were f
NBD and rhodamine are also shown at the bottom of each image. Scale bar indicate
although magnifications of all images are the same. The confocal images were sufor 30 min at 37 jC in the presence of wortmannin or
nigericin and kept in the presence of the inhibitors during
the transfection. PCL–DNA complexes (0.25 ml, 1 Ag
DNA) were added to the cells, which were then incubated
for 3 h at 37jC. The cells were washed twice with
RPMI1640 and cultured for 48 h in 2 ml of 10% FBS-RPMI.
Luciferase activity was assayed with a Pikkagene Assay Kit
(Toyo Ink Co., Ltd.), and the protein concentration of cell
lysates was determined by using a BCA Protein Assay Kit
(Pierce).3. Results
3.1. Intracellular trafficking of PCL–DNA complexes
At first, PCLs composed of dioleoylphosphatidyethanol-
amine (DOPE), cetyl PEI (18.9 mol% cetyl groups grafted
on to PEI with an average molecular weight of 1800), and a
trace of N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)-phosphati-
dylethanolamine (NBD-PE) were prepared and complexed
with plasmid DNA (gWIZk-GFP) pre-labeled with rhoda-
mine (Rh-DNA). The double-labeled complex was applied
to HT1080 human fibrosarcoma cells, and the intracellular
trafficking of NBD-PE/PCL and Rh-DNAwas monitored by
confocal laser scan microscopy. As shown in Fig. 2, theafter transfection by PCLs. HT-1080 cells were incubated with NBD-PE-
smid DNA(gWIZ-GFP) complexes at 37 jC for the indicated times and
set on the middle of nuclei of the most of cells. The NBD-labeled lipid is
ixed, and the nuclei were stained with DAPI (purple). Merged images of the
s 20 Am. Scale bar is shown on only one image for the sake of image clarity,
perimposed with Nomarski differential interference contrast images.
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was observed at the same locations (see merged images) on
the surface and in the cytoplasm of the cells at 1 h after the
addition of the complex, indicating that the complex bound
to the cells and became internalized. Three to five hours
later, besides the complex in the cytoplasm, Rh-DNA
fluorescence was observed in the nuclei, which were stained
with 4V, 6-diamidino-2-phenylindole (DAPI, purple), indi-
cating entry of the gene into the nucleus. Interestingly, no
green fluorescence was observed in the nuclei, suggesting
that the liposomal lipid had detached from the complex and
remained in the cytoplasm, maybe in the endosomes. In fact,
NBD fluorescence was observed in the cytoplasm (see
images at 5 h), most of which was not associated with
rhodamine fluorescence.
We next examined the intracellular trafficking of another
double-labeled PCL–DNA complex, i.e., FITC-cetyl PEI/
PCL and Rh-DNA (Fig. 3). Similar images as shown in Fig.
1 were observed at 1 h after the addition of the PCL–DNA
complexes. Three to five hours later, Rh-DNA fluorescence
was observed in the nuclei. Interestingly, the fluorescence of
Rh-DNA in the nuclei overlapped the fluorescence of FITC-
cetyl PEI at 3 and 5 h after the addition of the PCL–DNA
complexes, indicating that cetyl PEI had entered the nucleus
as a complex with the DNA. In line with these results, theFig. 3. Intracellular trafficking of cetyl-PEI and plasmid DNA in HT-1080 cells af
PCL containing FITC-labeled cetyl PEI (FITC-cetyl PEI/DOPE= 0.05:1) and rho
and examined by confocal laser scan microscopy. The focal plane of each sampl
indicates the localization of FITC-cetyl PEI; and red fluorescence, that of plasmid
Scale bar indicates 20 Am. Scale bar is shown on only one image for the sake of im
images were superimposed with Nomarski differential interference contrast imagefluorescence of Rh-DNA in the cytoplasm also overlapped
that of FITC-cetyl PEI, indicating that the cetyl PEI–DNA
complexes were intact in the cytoplasm, possibly in the
endosomes. We also examined the distribution of FITC-
cetylPEI/PCL without Rh-DNA in the cells, and observed
the presence of FITC fluorescence in the nuclei (data not
shown).
Quantitative data of intracellular distribution of PCL–
DNA components are summarized in Fig. 4. NBD fluores-
cence was co-localized with or separated from Rh-DNA in
the cytophasmic area (Fig. 4, upper panel), where Rh-DNA
was present as a complex with FITC-cetyl PEI (Fig. 4, lower
panel). In the nuclear area, only little NBD fluorescence was
observed while Rh-DNA was present as a complex form
with FITC-cetyl PEI.
3.2. Effect of endosomal pathway inhibitors on intracellular
trafficking of PCL–DNA complexes
To confirm the endosomal pathway of PCL–DNA uptake
by HT1080 cells, we investigated the intracellular trafficking
of PCL–DNA complex in the presence of wortmannin,
which is known to inhibit phosphatidylinositol-3 kinase
and therefore inhibits endocytosis [13,14], or nigericin,
which is able to dissipate the pH gradient across the endo-ter transfection by PCL. HT-1080 cells were incubated with the complex of
damine-labeled plasmid DNA(gWIZ-GFP) at 37 jC for the indicated times
e was set on the middle of nuclei of the most of cells. Green fluorescence
DNA. The cells were fixed and the nuclei were stained with DAPI (purple).
age clarity, although magnifications of all images are the same. The confocal
s.
Fig. 5. Effect of inhibitors of the endosomal pathway on intracellular
trafficking of plasmid DNA in HT-1080 cells after transfection by PCL. HT-
1080 cells were preincubated with 1%DMSO-RPMI1640 (a, c), 10 AM
wortmannin (b) or 10 AM nigericin (d) at 37 jC for 30 min, then incubated
with PCL and rhodamine-labeled plasmid DNA complexes at 37jC for 1 h
(a, b) or 6 h (c, d), and examined by confocal laser scan microscopy. The
focal plane of each sample was set on the middle of nuclei of the most of
cells. Scale bar indicates 20 Am. Magnifications of all images are the same.
The confocal images were superimposed with Nomarski differential
interference contrast images.
Fig. 6. Effect of inhibitors of endosomal pathway on PCL-mediated gene
transfer. PCLs composed of cetyl PEI and DOPE (0.05:1 as molar ratio)
were complexed with 1 Ag of pCAG-luc3 at an N/P ratio of 24. HT-1080
cells were preincubated with wortmannin (left panel) or nigericin (right
panel) at 37 jC for 30 min. Then the cells were incubated with PCL/DNA
complexes at 37 jC for 3 h. After further incubation for 48 h, the cells were
solubilized and the luciferase activity and protein concentration were
determined. Data are expressed as relative light units (RLU) per milligram
of protein along with S.D. bars. Significant difference from control;
*P< 0.05; **P < 0.01.
Fig. 4. Intracellular trafficking of PCL–DNA components in HT-1080 cells
after transfection by PCLs. HT-1080 cells were incubated with NBD-PE-
labeled PCL(cetyl PEI/DOPE/NBD-PE = 0.05:1:0.05) and rhodamine-
labeled plasmid DNA(gWIZ-GFP) complexes at 37 jC for 5 h and
examined by confocal laser scan microscopy. The cells were fixed and the
nuclei were stained with DAPI. The fluorescence spots with NBD alone,
rhodamine alone or both co-localized in the cytoplasmic area and nuclear
area were determined about 50 cells randomly selected (upper panel).
Intracellular distribution of PCL containing FITC-labeled cetyl PEI and
rhodamine-labeled plasmid DNA after 5 h injection was also examined
(lower panel). The data are shown as spot number per cell.
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DNA complexes were endocytosed by HT1080 cells at 1
h after addition of the complexes in the absence of wort-
mannin. In contrast, the complexes were observed only at the
edge of the cells in the presence of wortmannin (Fig. 5b).
The effect of nigericin is shown in Fig. 4c and d. Gene
transfer to nuclei was observed at 6 h after the addition of
PCL and Rh-DNA complexes in the absence of nigericin. On
the contrary, in its presence the fluorescence of Rh-DNA at
this time was observed only in the cytoplasm. Since wort-
mannin inhibits endocytosis and nigericin inhibits pH-low-
ering in endosomes, the evidence obtained here strongly
suggests that PCL–DNA complexes observed in the cyto-
plasmic area resided not in the cytosol but within the endo-
somes. Furthermore, the evidence indicates that endosomal
pH-lowering is necessary for the release of cetyl PEI–DNA
complexes into the cytoplasm, which process is prerequisite
for gene entry into the nucleus mediated by the polycation.
Next, the actual inhibition of gene transfer by both
endosomal pathway inhibitors was examined. The luciferase
gene was used as a reporter gene, and its expression was
quantified. As shown in Fig. 6, either wortmannin or
nigericin inhibited the gene transfer in a dose-dependent
manner. The data support the idea that PCL-mediated gene
transfer occurs via the endosomal pathway.4. Discussion
For gene therapy, safe and efficient gene transfer systems
are awaited. The PCL, a novel non-viral gene transfer
system, was developed to have the advantages of both
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are generally used as non-viral gene transfer systems. PCLs
were prepared by modifying liposomes with cetyl PEI, since
we originally observed that liposomes modified with cetyl
PEI derivative might deliver agents into the cytosol via the
endosomal pathway [16]. PCLs showed high transfection
efficiency, low cytotoxicity and low hemolytic activity in
comparison with conventional cationic liposomes [11], and
were found to be effective in the presence of serum and in
vivo [17]. To elucidate the mechanism of PCL-mediated
gene transfer, we investigated the intracellular trafficking of
PCL components and associated DNA plasmid.
Our observations indicate that PCL–DNA complexes
were taken up into HT1080 cells as intact complexes. Then,
the liposomal lipid became detached from the cetyl PEI–
DNA complexes in the endosomes, since the fluorescence
of the liposomal remained in the cytoplasmic area. Interest-
ingly, the DNA entered into the nucleus as a complex with
cetyl PEI, suggesting that the DNA–cetyl PEI complex had
dissociated from the PCL lipids in the endosome before
being released into the cytosol and entering the nucleus.
It is uncertain whether the present formulation of PCL
resulted in liposomes or lipid complexes, since DOPE is
known to be a non-bilayer lipid. However, cetyl PEI having
bulky polar group may stabilize bilayer form of DOPE. In
fact, we observed liposome-like structure under light micro-
scope. Furthermore, PCLs composed of bilayer-forming
lipids such as egg yolk phosphatidylcholine and dipalmi-
toylphosphatidylcholine (DPPC) were also effective for
gene transfer [11].
PEI is a positively charged polymer and is used as a gene
transfer vector by itself [18–20], although the molecular
weight of PEI used for this purpose is usually quite high (25
to 50 kDa), compared with that of the PEI used for PCLs
(1800 Da was used in this study). PEI is a suitable poly-
cation for gene transfer, as it has great ability to induce
DNA compaction. Furthermore, PEI is effective for gene
delivery without using agents for the purpose of endosomal
destruction such as chloroquine and fusogenic peptides,
since PEI has a number of amines that can be protonated
under low pH conditions, whose proton excess induces the
influx of chloride ions into the endosome, resulting in
osmotic bursting of the endosome. This so-called proton
sponge effect [21] causes the release of the gene into the
cytosol, from which it enters the nucleus. In fact, polyca-
tions such as PEI and polylysine were reported to accelerate
gene entry into nuclei from the cytosol [22,23]. Further-
more, PEI with molecular weight of 25,000 has the ability to
enter the nucleus accompanied by DNA or not [24].
Interestingly, many nuclear localizing signal (NLS) peptides
contain a number of basic amino acids, i.e., lysine and
arginine [25–27]. For example, the NLS of SV40 large T
antigen contains five successive basic amino acids in its
sequence. It is possible that polycations including certain
peptides having multiple basic amino acid residues have the
ability to pass through the nuclear membrane, although it isnot clear whether there are some specific transfer systems on
the nuclear membrane for polycations. In any event, cetyl
PEI in PCLs is important not only for electrostatic interac-
tion with DNA, compaction of DNA, interaction with the
cell membrane, and the release of DNA into the cytosol
from the endosome, but also for the entry of DNA into the
nucleus from the cytosol.
Finally, we confirmed that the PCL-mediated gene trans-
fer occurred through the endosomal pathway by using
inhibitors for the pathway. Phosphatidylinositol 3-kinase is
known to play a role in endocytosis; and, therefore, wort-
mannin, an inhibitor of this enzyme, would be expected to
inhibit endocytosis [13,14]. By the observation under the
confocal laser scan microscope, the uptake of PCL–DNA
complexes into HT1080 cells was inhibited in the presence
of wortmannin, suggesting that PCL–DNA complex was
actually endocytosed by the cells before the gene expression.
Furthermore, the PCL–DNA complexes observed in the
cytoplasm in the absence of wortmannin are suggested to
be located in endosomes. In the presence of nigericin, a
potassium ionophore [15], PCL–DNA complexes were
observed in the cytoplasmic area even after a 6-h incubation,
and no fluorescence was observed in the nuclear area.
Therefore, the lowering of pH in endosome might be a key
step for releasing the cetyl PEI–DNA complexes into
cytosol. The decreased gene expression shown in Fig. 6,
however, was not fully proved to be due to the inhibition of
the endosomal pathway, since the possibility that these
inhibitors affect the luciferase-expressing pathway was not
neglected.
Taken together, our data indicate the following possible
mechanism of gene transfer by PCLs: Step I, Complex
formation of PCL and DNA by electrostatic interaction
occurs. Since positively charged PCL is dominant compared
with the negatively charged DNA in the PCL–DNA com-
plex (N/P ratio was 36), the complex has a net positive
charge. This positivity may contribute to the binding of the
complex with the negatively charged cell membrane, as in
other cationic systems [28,29]. Step II, The PCL–DNA
complex is then taken up into cells by endocytosis. Step III,
Cetyl PEI–DNA becomes detached from the PCL liposo-
mal lipids under the low pH condition of the endosome [30],
and the effective release of cetyl PEI–DNA complex into
the cytosol is achieved by both the membrane destabiliza-
tion effect the liposomes and the osmotic bursting of endo-
somes via the proton sponge effect of PEI. Step IV, Finally
cetyl PEI accelerates the entry of DNA into the nucleus.
In general, the key step of gene delivery is thought to be
not the delivery of DNA into the cytosol through the
endosomal pathway but rather the entry of cytosolic DNA
into the nucleus when cationic liposomes are used as a non-
viral vector [31,32]. Therefore, gene delivery is cell-cycle-
dependent and effective gene delivery is achieved only in
dividing cells. If PEI has the ability to enter into the nucleus
in nondividing cells, the PCL may have the dual advantages
of both cationic liposomes for cytosolic delivery of DNA
M. Sugiyama et al. / Biochimica et Biophysica Acta 1660 (2004) 24–3030and polycations for delivery of cytosolic DNA into the
nucleus. Alternatively, if PEI cannot pass through nuclear
membrane, still PEI has ability to enhance interaction of
foreign DNA to chromatins during cell division.Acknowledgements
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